Drs. Winter and Brody discuss that this COVID-related drug (Remdesivir) has gotten a lot of media attention. 
"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial"  www.thelancet.com Published online April 29, 2020 https://doi.org/10.1016/S0140-6736(20)31022-9

Drs. Winter and Brody discuss that this COVID-related drug (Remdesivir) has gotten a lot of media attention. "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial" www.thelancet.com Published online April 29, 2020 https://doi.org/10.1016/S0140-6736(20)31022-9

Drs. Winter and Brody discuss that this COVID-related drug (Remdesivir) has gotten a lot of media attention.&nbsp;
"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial"&nbsp; www.thelancet.com Published online April 29, 2020 https://doi.org/10.1016/S0140-6736(20)31022-9

Episode 3: 05/07/20 - Approaching Clinical Trials through a "COVID19 lens"

Have any connection and interest in understanding not only pancreatic cancer, but to cancer in general? Listen to a surgeon scientist and a Ph.D. scientist, both in the middle of their careers and leaders at their respective institutions, who have combined 50+ years of experience in the field--discuss with thought leaders in oncology the politics, the landscape, the science, the clinical trials, the challenges, and the opportunities within the field of cancer research.

Share Episode 3: 05/07/20 - Approaching Clinical Trials through a "COVID19 lens"

Sign up to save your podcasts

Episode 3: 05/07/20 - Approaching Clinical Trials through a "COVID19 lens"

Episode 3: 05/07/20 - Approaching Clinical Trials through a "COVID19 lens"

More shows like The Pancreatic Cancer Podcast

Purple Rainbow Pancreatic Cancer Podcast